No internet connection — showing the saved version of the page.

BIO-TECHNE Corp

USUSD
← to the screener

BIO-TECHNE Corp (US:TECH) — Biotechnology: Biological Products (No Diagnostic Substances). Number of exchanges where the company shares trade: 1. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
bio-techne.com
Investor relations
investors.bio-techne.com/
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Headquarters
Minneapolis
Founded
1976
IPO
1989-02-09
Shares outstanding
157.06 M as of 2026-10-09
DateSharesChange
09.10.2026157.06 M+0.2%issuance (dilution)
17.08.2026156.82 M
Share count from the company reports. A split is detected by a jump in the count by a whole number of times.
Market cap
11.4 B USD
Industry (SIC)
Biological Products, (No Diagnostic Substances)
Legal form
S2K8
ISIN
US09073M1045
LEI
54930073RLKQ51TILZ35
P/E
66.6
EPS
1.09 USD
|
5.27
Graham number
11.90 USD price 510% above
ROE
8.3%
Payout ratio
29.1%
FCF
308 M USD
Payout / FCF
16%
Debt
200 M USD
net cash
Dividend streak
3 y
Earnings, FCF and dividends paid — for the 12 months to 30.09.2026 (the company's latest report).
Net income
172 M USD 12 mo.
For the 12 months to 30.09.2026 (4 quarters)
Revenue1.23 B USD
− Expenses987 M USD
Gross profit808 M USD
Net income172 M USD
History by quarter
RevenueExpensesLoss
31.12.2023: Revenue 273 M · Expenses 235 M · Operating profit 38.0 M · Net income 27.5 M31.03.2024: Revenue 303 M · Expenses 236 M · Operating profit 67.0 M · Net income 49.1 M30.06.2024: Revenue 306 M · Expenses 260 M · Operating profit 45.8 M · Net income 40.6 M30.09.2024: Revenue 289 M · Expenses 249 M · Operating profit 40.0 M · Net income 33.6 M31.12.2024: Revenue 297 M · Expenses 250 M · Operating profit 47.4 M · Net income 34.9 M31.03.2025: Revenue 316 M · Expenses 277 M · Operating profit 38.7 M · Net income 22.6 M30.06.2025: Revenue 317 M · Expenses 341 M · Operating profit −23.9 M · Net income −17.7 M30.09.2025: Revenue 287 M · Expenses 239 M · Operating profit 47.7 M · Net income 38.2 M31.12.2025: Revenue 296 M · Expenses 241 M · Operating profit 54.5 M · Net income 38.0 M31.03.2026: Revenue 311 M · Expenses 236 M · Operating profit 75.5 M · Net income 51.0 M30.06.2026: Revenue 321 M · Expenses 247 M · Operating profit 74.3 M · Net income 54.6 M30.09.2026: Revenue 300 M · Expenses 263 M · Operating profit 36.6 M · Net income 28.3 M
12.202309.2026
Green above orange is profit (revenue − expenses); red below zero is a loss.
NAV
13.79 USD · P/NAV 5.27
Balance sheet date30.09.2026
Assets2.64 B USD
− Liabilities471 M USD
= NAV (equity of the company's shareholders)2.17 B USD
− Goodwill972 M USD
− Intangible assets287 M USD
= Tangible NAV907 M USD
Shares157 053 885
NAV per share13.79 USD
Tangible NAV per share5.77 USD
Share price (TECH)72.6300 USD
P/NAV5.27
NAV history
Balance sheet dateNAVNAV per share
30.09.20262.17 B USD13.79 USD
30.06.20262.11 B USD13.51 USD
31.03.20262.09 B USD13.32 USD
31.12.20252.01 B USD12.90 USD
30.09.20251.97 B USD12.62 USD
30.06.20251.92 B USD12.38 USD
31.03.20252.02 B USD12.87 USD
31.12.20242.08 B USD13.16 USD
Description

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. — Wikipedia

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
common stock
US USA StocksTECHUSD72.63 -0.22%common stock
depositary receipt
SA B3 Sao PauloT1CH34BRL—depositary receipt

Price

US:TECH · USD
Hover / tap a day — open, close, high and low prices

Dividends

Per year, US:TECH: 0.32 USD (4 paym.)

BIO-TECHNE Corp (TECH) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 0.32 USD per share (payments: 4). That is about 0.44% of the current share price. Based on payment history, the next ex-dividend date is expected around 12.02.2027. Uninterrupted dividend history: 3 years.

Ex-datePaymentAmount%TypeTicker
2026-11-132026-11-230.0800 USD0.1/0.4 %quarterlyUS:TECH
2026-08-242026-09-040.0800 USD0.1/0.4 %quarterlyUS:TECH
2026-05-182026-05-290.0800 USD0.2/0.7 %quarterlyUS:TECH
2026-02-132026-02-270.0800 USD0.1/0.5 %quarterlyUS:TECH
2025-11-172025-11-280.0800 USD0.1/0.5 %quarterlyUS:TECH
2025-08-182025-08-290.0800 USD0.1/0.6 %quarterlyUS:TECH
2025-05-192025-05-300.0800 USD0.2/0.7 %quarterlyUS:TECH
2025-02-142025-02-280.0800 USD0.1/0.5 %quarterlyUS:TECH
2024-11-082024-11-220.0800 USD0.1/0.4 %quarterlyUS:TECH
2024-08-192024-08-300.0800 USD0.1/0.4 %quarterlyUS:TECH
2024-05-102024-05-240.0800 USD0.1/≈0.4 %quarterlyUS:TECH
2024-02-092024-02-260.0800 USD0.1/≈0.4 %quarterlyUS:TECH
2023-11-092023-11-240.0800 USD0.1/≈0.4 %quarterlyUS:TECH